Now Serving
Latest News
Interviews
Market Reports
Company Insights

ASX:OB1

Email Alerts for:
ASX:OB1

No news available...

Subscribe

Subscribe for our daily email digest

Latest Company News

Alterity Therapeutics Receives Positive FDA Feedback on ATH434 Phase 3 Program

An hour ago

Variscan Mines Announces Management and Board Changes

An hour ago

Ainsworth Game Technology Faces Second Takeover Bid

An hour ago

Atomo Diagnostics Completes $4 Million Capital Raise

An hour ago

Aeris Resources Expands Golden Plateau Drill Program After High-Grade Gold Results

An hour ago

Market Gloom Deepens Amidst Global Uncertainty

An hour ago

Latest Media Releases

INOVIQ - Weaponising Exosomes for Breast Cancer treatment

A year ago

Immutep - Excellent Survival Data from INSIGHT-003 Trial in NSCLC

A year ago

BluGlass secures A$2.9M CLAWS Hub sub-contract

A year ago

Immutep - Positive Data from Phase II Trial in Soft Tissue Sarcoma

A year ago

Lithium Universe - Amendment to Placement and Launch of Entitlement Offer

A year ago

Lithium Universe - Quarterly Activities/Appendix 5B Cash Flow Report

A year ago

BluGlass - Quarterly Activities Report / Appendix 4C - 30 Sept 2024

A year ago

Dotz Nano - Quarterly Activities/Appendix 4C Cash Flow Report

A year ago

INOVIQ - Quarterly Business Update and Appendix 4C - September 2024

A year ago

BPH Energy - Quarterly Activities/Appendix 4C Cash Flow Report

A year ago

ABN 31 117 966 328
Disclaimer
Privacy Policy
FNN is a Subsidiary of Sequoia Financial Group Ltd

Categories

Latest News
Market Reports
Interviews
Commentary and Analysis
Insights

Newsletter

Receive Daily News to your email

Copyright Finance TV Pty Ltd All Rights Reserved

Now Serving
Latest News
Interviews
Market Reports
Company Insights

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?

Daily News